Trial Profile
Study of mono- and co-activation of the GIP and GLP-1 receptors inhibits bone resorption in overweight/obese men
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Gastric inhibitory polypeptide (Primary) ; Glucagon-like peptide-1 (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 17 Oct 2018 New trial record
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes